Table 2.
Selected Health Promotion Programs, Health Screenings, and Disease Management by Worksite Size.a
| Programs or Activities | Total, % (95% Cl) | 10–24, % (95% Cl) | 25–49, % (95% Cl) | 50–99, % (95% Cl) | 100–249, % (95% Cl) | 250–499, % (95% Cl) | 500+, % (95% Cl) |
|---|---|---|---|---|---|---|---|
| Programs | |||||||
| Any health promotion program | 46.1 (43.7–48.6) | 39.5 (36.1–42.9) | 43.9 (39.1–48.7) | 59.6 (52.4–66.4) | 69.4 (59.9–77.6) | 83.0 (72.0–90.2) | 91.8 (86.4–95.2) |
| Physical activity | 28.5 (26.2–30.8) | 24.7 (21.7–28.0) | 23.7 (19.8–28.1) | 35.7 (28.5–43.5) | 48.0 (39.3–56.9) | 63.8 (51.2–74.7) | 75.8 (67.7–82.4) |
| Nutrition | 23.1 (21.1–25.4) | 19.8 (17.1–22.9) | 20.0 (16.3–24.4) | 27.1 (20.6–34.6) | 39.9 (31.4–49.0) | 59.5 (46.0–71.7) | 75.6 (67.8–82.0) |
| Stress | 19.6 (17.7–21.8) | 17.1 (14.5–20.0) | 15.3 (12.1–19.3) | 22.6 (16.6–29.9) | 39.0 (29.8–49.2) | 43.3 (30.8–56.7) | 73.1 (64.7–80.1) |
| Tobacco | 18.5 (16.7–20.5) | 16.1 (13.7–18.9) | 14.2 (11.1–18.1) | 21.4 (16.2–27.8) | 35.0 (26.1–45.0) | 46.1 (34.3–58.4) | 73.5 (65.0–80.5) |
| Weight control | 17.4 (15.6–19.4) | 14.0 (11.7–16.6) | 14.4 (11.1–18.5) | 23.4 (17.9–29.9) | 33.9 (25.2–43.8) | 45.3 (31.8–59.5) | 66.3 (57.7–74.3) |
| Alcohol/drug use | 14.4 (12.7–16.4) | 14.0 (11.6–16.7) | 10.8 (8.0–14.4) | 12.4 (8.8–17.2) | 26.2 (18.2–36.2) | 33.5 (22.3–47.0) | 52.3 (43.0–61.5) |
| Musculoskeletal/arthritis/back pain | 12.1 (10.6–13.9) | 12.0 (9.8–14.5) | 7.6 (5.4–10.5) | 9.7 (6.3–14.5) | 26.3 (18.3–36.2) | 31.0 (18.8–46.5) | 41.0 31.2–51.5) |
| Sleep | 9.9 (8.3–11.6) | 10.0 (8.0–12.5) | 6.4 (4.2–9.7) | 9.6 (5.5–16.3) | 17.5 (10.7–27.4) | Suppressed | 31.7 (22.9. 42.0) |
| Lactation support | 7.6 (6.3–9.1) | 4.8 (3.4–6.6) | 6.7 (4.5–9.9) | 11.8 (7.0–19.1) | 18.0 (11.6–26.9) | 16.8 (10.0–26.9) | 58.6 (48.9–67.7) |
| Screenings | |||||||
| Health risk assessment | 25.5 (23.3–27.9) | 21.6 (18.7–24.9) | 23.1 (19.0–27.8) | 31.3 (24.4–39.5) | 43.9 (35.7–52.4) | 52.0 (39.1–64.6) | 68.7 (59.3–76.8) |
| Blood pressure | 22.5 (20.5–24.6) | 19.0 (16.4–22.0) | 18.5 (14.9–22.7) | 27.0 (21.1–33.9) | 44.8 (36.2–53.8) | 51.0 (37.4–64.5) | 79.0 (71.7–84.8) |
| Cholesterol | 19.7 (17.7–21.7) | 16.8 (14.2–19.7) | 15.7 (12.4–19.8) | 22.9 (17.6–29.3) | 41.3 (33.0–50.1) | 46.0 (33.0–59.6) | 60.2 (50.9–68.8) |
| Diabetes | 19.0 (17.2–21.0) | 16.2 (13.7–19.0) | 15.3 (12.0–19.2) | 21.3 (16.2–27.5) | 41.5 (33.2–50.3) | 46.3 (33.0–60.0) | 61.8 (52.6–70.2) |
| Obesity | 18.2 (16.3–20.3) | 16.0 (13.6–18.8) | 14.5 (11.2–18.5) | 18.5 (12.9–25.8) | 38.1 (29.7–47.4) | 45.9 (32.2–60.2) | 67.2 (58.5–74.8) |
| Mammography | 11.3 (9.8–13.1) | 11.5 (9.3–14.0) | 6.2 (4.1–9.3) | 13.4 (9.2–19.2) | 18.1 (11.9–26.7) | Suppressed | 40.1 (31.9–48.8) |
| Colorectal cancer | 7.7 (6.5–9.2) | 6.3 (4.8–8.1) | 6.0 (3.9–9.2) | 12.0 (8.0–17.7) | 14.3 (9.2–21.5) | Suppressed | 27.6 (20.2–36.5) |
| Cervical cancer | 7.3 (6.1–8.8) | 6.1 (4.6–7.9) | 5.1 (3.1–8.1) | 11.3 (6.6–18.7) | 14.8 (9.5–22.3) | Suppressed | 26.0 (18.8–34.7) |
| Depression | 5.4 (4.3–6.6) | 4.4 (3.2–6.1) | 4.6 (2.8–7.4) | 6.3 (3.6–10.8) | 11.5 (6.4–19.8) | Suppressed | 23.8 (17.2–31.8) |
| Disease management | |||||||
| Hypertension | 19.7 (17.7–21.9) | 16.9 (14.3–19.8) | 18.3 (14.5–24.7) | 18.4 (13.3–24.9) | 40.0 (31.7–50.1) | 52.6 (38.8–66.0) | 75.4 (65.8–82.9) |
| Diabetes | 19.5 (17.6–21.7) | 16.8 (14.2–19.7) | 18.3 (14.5–22.9) | 18.2 (13.1–24.7) | 37.4 (28.4–47.3) | 55.4 (40.6–69.3) | 75.9 (66.4–83.4) |
| High cholesterol | 18.9 (17.0–21.1) | 16.3 (13.8–19.2) | 17.4 (13.7–21.8) | 17.7 (12.6–24.2) | 38.9 (29.7–49.0) | 44.8 (30.6–59.9) | 71.7 (61.7–80.0) |
| Obesity | 18.6 (16.6–20.7) | 16.0 (13.4–18.9) | 17.6 (13.9–21.9) | 16.1 (11.3–21.9) | 38.5 (29.2–48.7) | 44.5 (30.0–60.0) | 74.4 (65.2–81.8) |
| Cancer/cancer survivorship | 16.6 (14.7–18.6) | 15.2 (12.7–18.0) | 14.0 (10.7–18.1) | 14.7 (9.9–21.3) | 32.5 (22.9–41.7) | 41.9 (28.0–57.3) | 62.6 (52.5–71.7) |
| Depression | 15.1 (13.4–17.0) | 11.3 (9.3–13.8) | 16.2 (12.7–20.5) | 15.1 (10.5–21.3) | 35.4 (26.5–45.4) | 43.2 (28.7–58.9) | 67.4 (57.5–75.9) |
| High-risk pregnancy | 11.4 (9.9–13.2) | 11.6 (9.4–14.2) | 7.4 (5.1–10.5) | 7.9 (4.9–12.4) | 21.9 (14.7–31.5) | 26.8 (15.9–41.4) | 49.9 (39.4–60.4) |
| Asthma | 11.2 (9.6–12.9) | 8.3 (6.5–10.7) | 13.0 (9.8–17.1) | 10.3 (6.6–15.6) | 24.7 (17.2–34.2) | 27.0 (15.6–42.6) | 57.8 (47.4–67.5) |
| Migraine/headache | 8.9 (7.5–10.5) | 7.9 (6.1–10.1) | 8.9 (6.4–12.3) | 4.9 (2.7–8.8) | 20.3 (12.9–30.4) | 21.6 (12.3–35.3) | 38.5 (28.6–49.4) |
Abbreviation: Cl, confidence interval.
a
We suppressed estimates with a sample size of less than 50 or a relative standard error above 30%.